Steven Burgess, Ph.D.

Patent Agent« back


EDUCATION
  • Ph.D., Chemistry, Portland State University, 2008
  • B.Sc. (Hons.) in Chemistry, University of Bristol, U.K., 1992
BAR ADMISSIONS
  • U.S. Patent and Trademark Office (Reg. No. 71,428)
HONORS AND AWARDS
  • Paul Emmett Outstanding Graduate Student Award, 2007
YEAR JOINED FIRM

2013

Practice Areas:

Patents

Technologies:

Chemical

TECHNICAL EXPERTISE

Dr. Burgess is a patent agent skilled in all aspects of chemistry. Dr. Burgess has more than 15 years of industrial experience in synthetic organic and medicinal chemistry including designing, synthesizing, and optimizing novel antimalarial and antibacterial drugs.

PRIOR PROFESSIONAL EXPERIENCE

DesignMedix, Inc.
Senior Scientist | 2008 – 2013
Designed and synthesized novel antimalarial and antibacterial drugs. Project manager for the preclinical testing of the lead RCQ candidate.

Portland State University
Research/Teaching Assistant | 2003 – 2008
Dissertation title: Design and synthesis of antimalarial drugs based on a chloroquine scaffold.

Maybridge PLC
Scientist | 2001 – 2003
Team Leader | 1999 – 2001
Senior Chemist | 1995 – 1999
Chemist | 1992 – 1995
Designed and synthesized screening libraries, and synthetic intermediates, and managed custom synthesis projects.

PROFESSIONAL ACTIVITIES
  • Reviewer, Journal of Medicinal Chemistry
PRESENTATIONS AND PUBLICATIONS
  • Burgess, SJ; Kelly, JX; Shomloo, S; Wittlin, S; Brun, R; Liebmann, K; Peyton, DH: Synthesis, Structure-Activity Relationship, and Mode-of-Action Studies of Antimalarial Reversed Chloroquine Compounds. J. Med. Chem. 2010, 53(17): 6477-6489.
  • Andrews S, Burgess SJ, Skaalrud D, Kelly JX, Peyton DH: Reversal agent and linker variants of reversed chloroquines: activities against Plasmodium falciparum. J. Med. Chem. 2010, 53(2):916-919.
  • Burgess SJ, Selzer A, Kelly JX, Smilkstein MJ, Riscoe MK, Peyton DH: A Chloroquine-like Molecule Designed to Reverse Resistance in Plasmodium falciparum. J. Med. Chem. 2006, 49(18):5623-5625.